Literature DB >> 28630080

The Potential of Pharmacogenomics to Advance Kidney Disease Treatment.

Kelly A Birdwell1, Cecilia P Chung2.   

Abstract

Entities:  

Keywords:  human genetics; mineral metabolism

Mesh：

Year:  2017        PMID： 28630080      PMCID： PMC5498348          DOI： 10.2215/CJN.05170517

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  19 in total

Review 1.  Pharmacogenetics and drug development: the path to safer and more effective drugs.

Authors:  Allen D Roses
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

2.  Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels.

Authors:  Conall M O'Seaghdha; Qiong Yang; Nicole L Glazer; Tennille S Leak; Abbas Dehghan; Albert V Smith; W H Linda Kao; Kurt Lohman; Shih-Jen Hwang; Andrew D Johnson; Albert Hofman; Andre G Uitterlinden; Yii-Der Ida Chen; Edward M Brown; David S Siscovick; Tamara B Harris; Bruce M Psaty; Josef Coresh; Vilmundur Gudnason; Jacqueline C Witteman; Yong Mei Liu; Bryan R Kestenbaum; Caroline S Fox; Anna Köttgen
Journal:  Hum Mol Genet       Date:  2010-08-12       Impact factor: 6.150

3.  A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype.

Authors:  Iain A M MacPhee; David W Holt
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

4.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

5.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Authors:  Glenn M Chertow; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

Review 6.  Pharmacogenomics in the clinic.

Authors:  Mary V Relling; William E Evans
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

7.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.

Authors:  K A Birdwell; B Decker; J M Barbarino; J F Peterson; C M Stein; W Sadee; D Wang; A A Vinks; Y He; J J Swen; J S Leeder; Rhn van Schaik; K E Thummel; T E Klein; K E Caudle; I A M MacPhee
Journal:  Clin Pharmacol Ther       Date:  2015-06-03       Impact factor: 6.875

8.  Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Authors:  Geoffrey A Block; Kevin J Martin; Angel L M de Francisco; Stewart A Turner; Morrell M Avram; Michael G Suranyi; Gavril Hercz; John Cunningham; Ali K Abu-Alfa; Piergiorgio Messa; Daniel W Coyne; Francesco Locatelli; Raphael M Cohen; Pieter Evenepoel; Sharon M Moe; Albert Fournier; Johann Braun; Laura C McCary; Valter J Zani; Kurt A Olson; Tilman B Drüeke; William G Goodman
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

9.  Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Authors:  Kelly E Caudle; Teri E Klein; James M Hoffman; Daniel J Muller; Michelle Whirl-Carrillo; Li Gong; Ellen M McDonagh; Katrin Sangkuhl; Caroline F Thorn; Matthias Schwab; Jose A G Agundez; Robert R Freimuth; Vojtech Huser; Ming Ta Michael Lee; Otito F Iwuchukwu; Kristine R Crews; Stuart A Scott; Mia Wadelius; Jesse J Swen; Rachel F Tyndale; C Michael Stein; Dan Roden; Mary V Relling; Marc S Williams; Samuel G Johnson
Journal:  Curr Drug Metab       Date:  2014-02       Impact factor: 3.731

10.  Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.

Authors:  Sohyun Jeong; In-Wha Kim; Kook-Hwan Oh; Nayoung Han; Kwon Wook Joo; Hyo Jin Kim; Jung Mi Oh
Journal:  Drug Des Devel Ther       Date:  2016-07-08       Impact factor: 4.162
View more
  1 in total

1.  Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome.

Authors:  Xiaolan Mo; Jiali Li; Yunfeng Liu; Xin Liao; Mei Tan; Yilu Chen; Fan He; Yanling He; Yingjie Li; Min Huang
Journal:  Pharmacogenomics J       Date:  2020-01-06       Impact factor: 3.550
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.